Summer Workshop: Fragment-based Compound Evolution

webinar

Wed, 21 Jul 2021, 16:00 CEST (Berlin)

Alexander Neumann, BioSolveIT

Summer Workshop: Fragment-based Compound Evolution

Fragment-based drug design (FBDD) receives more and more attention in the scientific community. The the fifth fragment-derived drug, sotorasib, received approval by the FDA for the treatment of non-small cell lung cancer this year. In this workshop we will discuss strategies around FBDD with recent med-chem use cases and how to utilize resources for lead optimization and idea generation. by thinking outside the box. Learn how to evolve a weak binder to a full-fledged drug candidate.

Participants can request a certificate of attendance.

Current news

Recap DrugSpace Spring 2021: Recordings Available
September 16, 2021 19:03
A few months have passed since the DrugSpace Symposium Spring and the results and discussions are still echoing. The speakers and participants made this event a pioneering success in the field of innovative drug hunting methods and strategies for medicinal chemistry enthusiasts. Under the slogan ‘Targets, Compounds, Spaces’, speakers across...
Read on
category
Software
Covalent Set Update: ChemDiv Library with over 41k Entries
September 14, 2021 11:35
As of today, BioSolveIT features another collaboration with a renowned expert and global leader in drug discovery chemistry. Together with ChemDiv we have processed and translated their huge library of compounds containing a covalent warhead into a ready-to-dock format for SeeSAR to be explored with covalent docking. The set features...
Read on
category
Software
Reaxense Covalent Compound Library Now Available
September 6, 2021 13:04
Reaxense and BioSolveIT have teamed up and processed a new covalent compound library into a user-friendly format. Reaxense offers over 12,000 unique molecules containing at least one covalent warhead, as well as many other project-focused sets and libraries. Too great of a potential to be missed out! For your convenience,...
Read on